SEC 13F Intelligence

Mn Services Vermogensbeheer B.V. / REGN

Mn Services Vermogensbeheer B.V.’s Regeneron Pharmaceuticals Position

Does Mn Services Vermogensbeheer B.V. own Regeneron Pharmaceuticals (REGN)? Yes — 41.2K shares worth $32M (+0.21% of its 13F portfolio) as of Q1 2026.

Position Value
$32M
Q1 2026
Shares
41.2K
% of Portfolio
+0.21%
Quarters Held
26
currently held

Position History REGN

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $6MQ2 ’19: $4MQ2 ’20: $46MQ3 ’20: $42MQ3 ’20Q4 ’20: $37MQ2 ’21: $36MQ3 ’21: $47MQ4 ’21: $51MQ4 ’21Q1 ’22: $53MQ2 ’22: $37MQ3 ’22: $41MQ4 ’22: $37MQ4 ’22Q1 ’23: $44MQ2 ’23: $37MQ3 ’23: $43MQ4 ’23: $45MQ4 ’23Q1 ’24: $42MQ2 ’24: $44MQ3 ’24: $43MQ4 ’24: $30MQ4 ’24Q1 ’25: $25MQ2 ’25: $21MQ3 ’25: $23MQ4 ’25: $32MQ4 ’25Q1 ’26: $32Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202641.2K$32M+0.21%
Q4 202541.2K$32M+0.20%
Q3 202540.5K$23M+0.15%
Q2 202540.0K$21M+0.15%
Q1 202539.6K$25M+0.19%
Q4 202442.5K$30M+0.20%
Q3 202441.3K$43M+0.30%
Q2 202442.3K$44M+0.32%
Q1 202443.3K$42M+0.30%
Q4 202350.7K$45M+0.40%
Q3 202352.5K$43M+0.42%
Q2 202351.2K$37M+0.34%
Q1 202353.2K$44M+0.45%
Q4 202251.3K$37M+0.41%
Q3 202259.5K$41M+0.43%
Q2 202262.7K$37M+0.35%
Q1 202275.4K$53M+0.35%
Q4 202180.1K$51M+0.30%
Q3 202178.4K$47M+0.29%
Q2 202177.2K$36M+0.28%
Q4 202076.1K$37M+0.26%
Q3 202074.8K$42M+0.33%
Q2 202073.7K$46M+0.39%
Q2 201913.7K$4M+0.05%
Q1 201913.7K$6M+0.06%
Q4 201813.5K$4M+0.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mn Services Vermogensbeheer B.V.’s full portfolio or all institutional holders of REGN.